Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alkermes plc stock logo
ALKS
Alkermes
$54.58
$41.71
$25.17
$55.28
$9.10B0.342.62 million shs1.65 million shs
Cigna Group stock logo
CI
Cigna Group
$287.50
-0.1%
$285.09
$239.51
$323.10
$76.12B0.291.59 million shs2.10 million shs
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$557.60
$453.88
$306.70
$628.92
$15.92B1.15304,413 shs356,575 shs
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$424.64
-0.2%
$392.87
$234.60
$430.20
$386.29B0.626.52 million shs3.92 million shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alkermes plc stock logo
ALKS
Alkermes
+5.53%+3.31%+32.09%+56.66%+88.21%
Cigna Group stock logo
CI
Cigna Group
+3.91%+1.98%+5.56%+6.36%-10.28%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
+2.58%+7.24%+25.14%+11.89%+71.03%
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
-0.48%+2.15%+12.36%+53.13%+38.01%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Alkermes plc stock logo
ALKS
Alkermes
$54.58
$41.71
$25.17
$55.28
$9.10B0.342.62 million shs1.65 million shs
Cigna Group stock logo
CI
Cigna Group
$287.50
-0.1%
$285.09
$239.51
$323.10
$76.12B0.291.59 million shs2.10 million shs
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$557.60
$453.88
$306.70
$628.92
$15.92B1.15304,413 shs356,575 shs
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$424.64
-0.2%
$392.87
$234.60
$430.20
$386.29B0.626.52 million shs3.92 million shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Alkermes plc stock logo
ALKS
Alkermes
+5.53%+3.31%+32.09%+56.66%+88.21%
Cigna Group stock logo
CI
Cigna Group
+3.91%+1.98%+5.56%+6.36%-10.28%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
+2.58%+7.24%+25.14%+11.89%+71.03%
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
-0.48%+2.15%+12.36%+53.13%+38.01%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Alkermes plc stock logo
ALKS
Alkermes
2.72
Moderate Buy$49.63-9.08% Downside
Cigna Group stock logo
CI
Cigna Group
2.77
Moderate Buy$338.3017.67% Upside
Medpace Holdings, Inc. stock logo
MEDP
Medpace
2.20
Hold$467.08-16.23% Downside
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
2.81
Moderate Buy$411.42-3.11% Downside

Current Analyst Ratings Breakdown

Latest UNH, ALKS, MEDP, and CI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/2/2026
Alkermes plc stock logo
ALKS
Alkermes
Boost Price TargetOutperform$53.00 ➝ $65.00
6/30/2026
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
Boost Price TargetOverweight$453.00 ➝ $468.00
6/29/2026
Alkermes plc stock logo
ALKS
Alkermes
Boost Price TargetOverweight$44.00 ➝ $65.00
6/29/2026
Alkermes plc stock logo
ALKS
Alkermes
Reiterated RatingNeutralUnderperform
6/24/2026
Alkermes plc stock logo
ALKS
Alkermes
Boost Price TargetBuy$54.00 ➝ $61.00
6/24/2026
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
Boost Price TargetBuy$450.00 ➝ $475.00
6/23/2026
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
Reiterated RatingOutperform
6/22/2026
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
Reiterated RatingBuy
6/22/2026
Alkermes plc stock logo
ALKS
Alkermes
Boost Price TargetBuy$42.00 ➝ $50.00
6/18/2026
Alkermes plc stock logo
ALKS
Alkermes
Reiterated RatingNeutral
6/18/2026
Alkermes plc stock logo
ALKS
Alkermes
Boost Price TargetBuy$50.00 ➝ $54.00
(Data available from 7/3/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Alkermes plc stock logo
ALKS
Alkermes
$1.48B6.16$1.67 per share32.60$11.02 per share4.95
Cigna Group stock logo
CI
Cigna Group
$274.90B0.28$40.90 per share7.03$158.90 per share1.81
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$2.53B6.29$17.02 per share32.77$16.30 per share34.21
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$449.71B0.86$21.22 per share20.01$110.49 per share3.84
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Alkermes plc stock logo
ALKS
Alkermes
$241.66M$0.9060.65188.21N/A9.78%9.26%5.66%7/28/2026 (Estimated)
Cigna Group stock logo
CI
Cigna Group
$5.96B$23.5912.198.611.112.26%19.75%5.30%7/30/2026 (Estimated)
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$451.12M$15.9135.0530.082.8317.19%120.89%24.79%7/22/2026 (Confirmed)
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$12.06B$13.2432.0720.421.712.68%14.65%4.77%7/16/2026 (Confirmed)

Latest UNH, ALKS, MEDP, and CI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
7/30/2026Q2 2026
Cigna Group stock logo
CI
Cigna Group
$7.58N/AN/AN/A$70.18 billionN/A
7/28/2026Q2 2026
Alkermes plc stock logo
ALKS
Alkermes
-$0.04N/AN/AN/A$459.62 millionN/A
7/22/2026Q2 2026
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$3.98N/AN/AN/A$690.69 millionN/A
7/16/2026Q2 2026
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$4.84N/AN/AN/A$110.76 billionN/A
4/30/2026Q1 2026
Cigna Group stock logo
CI
Cigna Group
$7.60$7.79+$0.19$6.26$66.29 billion$68.52 billion
4/22/2026Q1 2026
Medpace Holdings, Inc. stock logo
MEDP
Medpace
$3.74$4.28+$0.54$4.28$697.82 million$706.60 million
4/21/2026Q1 2026
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$6.76$7.23+$0.47$6.90$109.84 billion$111.65 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Alkermes plc stock logo
ALKS
Alkermes
N/AN/AN/AN/AN/A
Cigna Group stock logo
CI
Cigna Group
$6.242.17%+172.77%26.45%5 Years
Medpace Holdings, Inc. stock logo
MEDP
Medpace
N/AN/AN/AN/AN/A
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$9.282.19%+12.57%70.09%15 Years

Latest UNH, ALKS, MEDP, and CI Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/3/2026
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
quarterly$2.322.26%6/15/20266/15/20266/23/2026
4/22/2026
Cigna Group stock logo
CI
Cigna Group
quarterly$1.562.22%6/4/20266/4/20266/18/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Alkermes plc stock logo
ALKS
Alkermes
0.85
2.27
1.70
Cigna Group stock logo
CI
Cigna Group
0.69
0.73
0.73
Medpace Holdings, Inc. stock logo
MEDP
Medpace
N/A
0.85
0.85
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
0.69
0.80
0.80

Institutional Ownership

CompanyInstitutional Ownership
Alkermes plc stock logo
ALKS
Alkermes
95.21%
Cigna Group stock logo
CI
Cigna Group
86.99%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
77.98%
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
87.86%

Insider Ownership

CompanyInsider Ownership
Alkermes plc stock logo
ALKS
Alkermes
4.59%
Cigna Group stock logo
CI
Cigna Group
0.60%
Medpace Holdings, Inc. stock logo
MEDP
Medpace
20.50%
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
0.28%
CompanyEmployeesShares OutstandingFree FloatOptionable
Alkermes plc stock logo
ALKS
Alkermes
2,050166.68 million159.03 millionOptionable
Cigna Group stock logo
CI
Cigna Group
67,700264.53 million262.95 millionOptionable
Medpace Holdings, Inc. stock logo
MEDP
Medpace
6,20028.56 million22.71 millionOptionable
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
390,000908.14 million905.60 millionOptionable

Recent News About These Companies

UnitedHealth (UNH) Stock Looks Reasonable Even After A 42% Gain
Top Healthcare Stocks To Watch Today - July 2nd
Cigna Brings AI to Specialty Pharmacy With Pharmacy Forward
Promising Healthcare Stocks To Keep An Eye On - July 1st
UnitedHealth Group (NYSE:UNH) Faces Medicare Reset

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Alkermes stock logo

Alkermes NASDAQ:ALKS

$54.58 0.00 (0.00%)
Closing price 07/2/2026 04:00 PM Eastern
Extended Trading
$53.52 -1.06 (-1.93%)
As of 07/2/2026 07:45 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. It has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical product candidates in development for neurological disorders. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ARISTADA INITIO for the treatment of schizophrenia in adults; VIVITROL for the treatment of alcohol and prevention of opioid dependence; and LYBALVI, an oral atypical antipsychotic drug candidate for the treatment of adults with schizophrenia and bipolar I disorder. It has collaboration agreements primarily with Janssen Pharmaceutica N.V., Janssen Pharmaceutica Inc, and Janssen Pharmaceutica International. The company also offers proprietary technology platforms to third parties to enable them to develop, commercialize, and manufacture products. Alkermes plc was founded in 1987 and is headquartered in Dublin, Ireland.

Cigna Group stock logo

Cigna Group NYSE:CI

$287.50 -0.27 (-0.10%)
Closing price 07/2/2026 03:59 PM Eastern
Extended Trading
$283.34 -4.16 (-1.45%)
As of 07/2/2026 07:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. In addition, it offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The Cigna Group was founded in 1792 and is headquartered in Bloomfield, Connecticut.

Medpace stock logo

Medpace NASDAQ:MEDP

$557.60 0.00 (0.00%)
Closing price 07/2/2026 04:00 PM Eastern
Extended Trading
$554.57 -3.03 (-0.54%)
As of 07/2/2026 05:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.

UnitedHealth Group stock logo

UnitedHealth Group NYSE:UNH

$424.64 -0.72 (-0.17%)
Closing price 07/2/2026 03:59 PM Eastern
Extended Trading
$424.80 +0.16 (+0.04%)
As of 07/2/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was founded in 1974 and is based in Minnetonka, Minnesota.